Thrivent Financial for Lutherans’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.59M | Buy |
99,715
+1,677
| +2% | +$60.4K | 0.01% | 980 |
|
2025
Q1 | $3.87M | Sell |
98,038
-5,130
| -5% | -$202K | 0.01% | 932 |
|
2024
Q4 | $3.11M | Sell |
103,168
-1,596
| -2% | -$48K | 0.01% | 1152 |
|
2024
Q3 | $2.45M | Buy |
+104,764
| New | +$2.45M | ﹤0.01% | 1301 |
|
2024
Q2 | – | Sell |
-38,490
| Closed | -$586K | – | 2589 |
|
2024
Q1 | $586K | Sell |
38,490
-17,730
| -32% | -$270K | ﹤0.01% | 2170 |
|
2023
Q4 | $960K | Sell |
56,220
-10,963
| -16% | -$187K | ﹤0.01% | 1863 |
|
2023
Q3 | $562K | Buy |
+67,183
| New | +$562K | ﹤0.01% | 2079 |
|